Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 1 of 1 for:    NCT03265132
Previous Study | Return to List | Next Study

A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD) (anaSTILLs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03265132
Recruitment Status : Terminated (Sobi has concluded that meeting the enrolment target of 81 patients will no longer be feasible within reasonable time.)
First Posted : August 29, 2017
Last Update Posted : June 12, 2019
Information provided by (Responsible Party):
Swedish Orphan Biovitrum

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Terminated
Actual Primary Completion Date : February 13, 2019
Actual Study Completion Date : May 23, 2019
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 12, 2020